CERUS CORP Debt Securities, Available-for-sale, Amortized Cost
CERUS CORP (CERS) had Debt Securities, Available-for-sale, Amortized Cost of $42.96 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-07-30
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $42.96M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $65.59M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $64.80M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $64.21M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $42.96M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $65.59M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $64.80M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $64.21M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $63.48M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $62.90M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $62.26M 10-K · filed 2026-03-02 |
| 2024-09-30 | $61.65M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $61.20M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $60.73M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $60.46M 10-K · filed 2025-02-26 |
| 2023-09-30 | $67.91M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $71.67M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $77.16M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $83.83M 10-K · filed 2024-03-05 |
| 2022-09-30 | $83.38M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $83.24M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $83.01M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $87.92M 10-K · filed 2023-03-01 |
| 2021-09-30 | $87.89M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $87.68M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $87.38M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $102.53M 10-K · filed 2022-02-22 |
| 2020-09-30 | $112.63M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $116.23M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $110.28M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $59.48M 10-K · filed 2021-02-25 |
| 2019-09-30 | $71.04M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $72.57M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $75.64M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $95.17M 10-K · filed 2020-02-21 |
| 2018-09-30 | $103.59M 10-Q · filed 2018-11-01 |
| 2017-12-31 | $50.87M 10-K · filed 2019-02-27 |
| 2015-09-30 | $91.14M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $94.44M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $99.48M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $33.46M 10-Q · filed 2015-11-06 |
| 2014-09-30 | $31.43M 10-Q · filed 2014-11-07 |
| 2013-12-31 | $36.83M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |